关键词 肌萎缩侧索硬化症 ALSFRS-R ⊿FS 生存时间 中图分类号 R741.041 ALSFRS-R score predicts survival time in als Zhong Lingling, Xu Jun, Jiang Weiwei, Zhao Xuexu, Li Zuohan (Nanjing Brain Hospital Affiliated to Nanjing Medical University,NanJing 210029) Abstract: objective To study the ...
肌萎缩侧索硬化症患者ALSFRS-R评分与生存时间相关性分析 声明：下面论文由《免费论文教育网》 http://www.PaperEdu.cn 用户转载自互联网，版权归原作者所有，本文档仅供参考，严禁抄袭！ 《免费论文教育网》
(ALSFRS-R) and its progression rate of ALSFRS-R correlation with survival time.Methods:Application of 2000 word Union of Neurology El Escorial diagnostic criteria retrospectively analyzed 64 case of amyotrophic lateral sclerosis clinical date,be ALSFRS-R score and the progress rate(⊿FS)and Kaplan-...
"Body Mass Index (BMI) as Predictor of ALSFRS-R Score Decline in ALS Pa- tients." Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(3), 212-216. doi:10.3109/21678421.2013.770028.Reich-Slotky R, Andrews J, Cheng B, Buchsbaum R, Levy D, Kaufmann P, Thompson JL (2013) ...
Tab.3 Logistic regression analysis of the cervical enlargement subitem of the ALSFRS-r score 变量βPOR95%可信区间下限上限正中神经CMAP波幅0.4390.0001.5511.2881.867尺神经CMAP波幅-0.0160.8520.9840.8291.167 表4 ALSFRS-r腰膨大亚项得分的Logistic回归分析 Tab.4 Logistic regression analysis of the lumbar enlarge...
Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener 2013;14(3):212-6... R Reich-Slotky,J Andrews,B Cheng,... - 《Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration》 被引量: 63发表: 2013年 The PRO-ACT...
Correlation between total ALSFRS-R score and %predicted SVC was the highest (r=.5519; p<.0001). Percent of SVC variance explained by dyspnea, orthopnea, respiratory insufficiency, and the entire respiratory subdomain was 13%, 10%, 12%, and 18%, respectively. Thirty percent of SVC variance...
During a three month run-in period, ALS Functional Rating Score-Revised (ALSFRS-R) and forced vital capacity (FVC) were assessed monthly and bone ... P Petrou,M Gotkine,Y Gothelf,... - 《Neurology》 被引量: 0发表: 2015年 Edaravone and its clinical development for amyotrophic lateral scl...
Two main analytical strategies were compared: (1) analyzing only the total score or (2) utilizing a subscale-based test (i.e. alternative strategy). For each analytical strategy, we calculated the empirical power and required sample size. Results: Both strategies are valid when there is no ...
gross motor functionPhase 3 study MCI186-19 demonstrated less loss of physical function with edaravone versus placebo, as measured by the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) total score. A 1-point drop in an individual ALSFRS-R item may be clinically meaningful...